|
29 Jan 2019 |
Purdue Pharma L.P. and Alivio Therapeutics Enter into Partnership to Advance ALV-107, a Non-Opioid Interstitial Cystitis/Bladder Pain Syndrome Treatment
|
|
24 Jan 2019 |
Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics for Novel Therapies Targeting RNA-mediated Diseases
|
|
24 Jan 2019 |
Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
|
|
24 Jan 2019 |
CAMP4 Therapeutics Announces Rare Disease Research Collaboration with Alnylam
|
|
24 Jan 2019 |
Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe
|
|
24 Jan 2019 |
B-MoGen Biotechnologies and CytoSen Therapeutics partner on research collaboration to develop next generation Natural Killer Cells for human therapeutics
|
|
23 Jan 2019 |
PeptiDream Announces New Peptide Drug Conjugate (PDC) Discovery Deal with Shionogi
|
|
23 Jan 2019 |
BioNTech to Acquire Antibody Generation Unit of MAB Discovery
|
|
23 Jan 2019 |
PrimeVax Immuno-Oncology Signs Exclusive Worldwide Dengue Virus License with US Army for Cancer Treatments
|
|
19 Jan 2019 |
Kyn Therapeutics Enters into Global Strategic Collaboration with Celgene to Develop Immuno-oncology Therapies
|
|
19 Jan 2019 |
Obsidian Therapeutics Announces Strategic Collaboration with Celgene to Develop Novel Cell Therapies with Tunable Immunomodulatory Factors, Opening Potential for CAR-T and Other Cellular Medicines in New Settings
|
|
18 Jan 2019 |
Free report: TOP 25 Pharma Groups analyzed for sales, R&D costs, operating and net income by business segments
|
|
17 Jan 2019 |
MD Anderson Cancer Center and Dragonfly Therapeutics announce strategic collaboration to take new immunotherapy candidates into clinical trials
|
|
15 Jan 2019 |
Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases
|
|
15 Jan 2019 |
Bio-Thera Solutions Ltd Partners with Cipla Ltd to Market Key Cancer Biosimilar
|
|
15 Jan 2019 |
Biomunex Pharmaceuticals signs a licensing agreement with Sanofi for the development of bi- and multi-specific antibodies
|
|
10 Jan 2019 |
SIRION Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System
|
|
10 Jan 2019 |
Elevian and Insilico Enter a Research Collaboration to Discover Drugs That Target Aging
|
|
10 Jan 2019 |
Daiichi Sankyo, Mitsubishi UFJ Capital and Tokyo Institute of Technology Announce Open Innovation Research on iPS Cell-derived Insulin Producing Cells in Japan
|
|
09 Jan 2019 |
Aptamer Group Announces Agreement with AstraZeneca to Explore Next-Generation Drug Delivery Devices
|
|
08 Jan 2019 |
Gilead Sciences and Yuhan Corporation Announce Collaboration and License Agreement to Develop Novel Investigational Treatments for Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
|
|
07 Jan 2019 |
bluebird bio and Inhibrx Announce Collaboration to Research, Develop and Commercialize CAR T Cell Immunotherapies
|
|
07 Jan 2019 |
Integral Molecular Enters Immuno-Oncology Target Discovery Collaboration with Daiichi Sankyo
|
|
07 Jan 2019 |
3SBio and Samsung Bioepis enter biosimilar collaboration agreement
|
|
07 Jan 2019 |
Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company
|
